Healthcare -
Biotechnology - NASDAQ - US
$ 0.1698
-5.67 %
$ 82.8 M
Market Cap
None
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Reviva Pharmaceuticals Holdings, Inc.
| Net Income | -39.3 M |
| Depreciation & Amortization | 0 |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 3.41 M |
| Change in Working Capital | 7.28 M |
| Others | 7.19 M |
| Free Cash Flow | -28.3 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Feb-2020 | Feb-2019 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (39.3) | (24.3) | (8.5) | (3.8) | (0.8) | (1.7) |
| Depreciation & Amortization | 0 | 0 | 0 | 591 | 645 | 17.7 K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 3.4 | 0.2 | 0.1 | 0 | 0 | 21.1 K |
| Other Operating Activities | 0.2 | 0.2 | (1.6) | 2.4 | 6.41 K | 28.2 K |
| Change in Working Capital | 7.3 | 5.0 | (0.7) | (2.3) | 0.6 | 0.5 |
| Cash From Operations | (28.3) | (19.0) | (10.7) | (3.7) | (0.2) | (1.1) |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Items | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 5.7 | 19 K | 98.5 K | 12.8 | 0 | 0.2 |
| Cash From Financing Activities | 33.2 | 7.8 | 31.6 | 12.8 | 100 K | 0.2 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | 4.8 | (11.2) | 20.9 | 8.8 | (0.1) | 0.1 |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (28.3) | (19.0) | (10.7) | (3.7) | (0.2) | (1.1) |